Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomised, Controlled, Open Label Trial on the Efficacy and Safety of Asunercept for Patients With Severe COVID-19 Disease

NCT04535674 is registered in ClinicalTrials.gov with Apogenix AG as lead sponsor.

NCT NCT04535674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04535674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomised, Controlled, Open Label Trial on the Efficacy and Safety of Asunercept for Patients With Severe COVID-19 Disease
Lead sponsor
Apogenix AG
Phase
Phase 2
Overall status
Completed
Start date
October 9, 2020
Completion date
December 21, 2021
Enrollment
438 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 induced pneumonia, covid19